Filter
1004
Filtered Results: 1004
Text search:
pharmaceutical
procurement
Featured
Recommendations
106
New Publications
307
Language
Document type
No document type
508
Studies & Reports
189
Guidelines
153
Strategic & Response Plan
65
Manuals
46
Fact sheets
18
Training Material
10
Situation Updates
9
Resource Platforms
3
Infographics
2
Brochures
1
Countries / Regions
Ethiopia
56
Kenya
50
Global
35
India
33
Uganda
28
South Africa
26
Sierra Leone
25
Nigeria
24
Liberia
23
Ghana
21
Namibia
21
Tanzania
20
Malawi
19
Nepal
17
Rwanda
17
Western and Central Europe
16
Zambia
16
Bangladesh
15
Ukraine
13
Zimbabwe
12
Philippines
12
Africa
12
Lesotho
11
Latin America and the Carribbean
9
Eastern Europe
9
Syria
8
Cambodia
8
Senegal
7
Congo, Democratic Republic of
7
Myanmar / Burma
7
Botswana
6
Indonesia
6
Eswatini/ Swaziland
6
Benin
5
Cameroon
5
Burkina Faso
5
Haiti
5
Asia
5
South–East Asia Region
5
West and Central Africa
4
East and Southern Africa
4
Guinea
3
Mozambique
3
North America
3
Papua New Guinea
3
Sudan
3
Thailand
2
Albania
2
Jordan
2
Middle East and North Africa
2
Western Pacific Region
2
Lebanon
2
Yemen
2
South Sudan
2
Pakistan
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
El Salvador
1
Fiji
1
Laos
1
Dominican Republic
1
Germany
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
Paraguay
1
Gabon
1
Maldives
1
Southern Africa
1
Belize
1
Costa Rica
1
Panama
1
Vietnam
1
Nicaragua
1
Brazil
1
Moldova
1
Russia
1
Central African Republic
1
Honduras
1
Mali
1
Libya
1
Somalia
1
Madagascar
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
506
Clinical Guidelines
55
Key Resources
46
Public Health
37
Pharmacy & Technologies
24
Women & Child Health
22
Capacity Building
5
Annual Report MEDBOX
1
Toolboxes
Pharmacy
108
AMR
96
COVID-19
65
HIV
59
TB
52
Rapid Response
26
NTDs
24
Health Financing Toolbox
22
Planetary Health
20
Malaria
16
Conflict
16
NCDs
15
Global Health Education
13
Mental Health
11
Ebola & Marburg
11
Caregiver
9
Natural Hazards
4
Polio
3
Refugee
2
Disability
2
Cholera
2
Specific Hazards
1
Zika
1
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro...
Updated 25 January 2021
11 April 2022
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
The Disaster Recovery Framework (DRF) Guide for the Health Sector provides guidance on how to implement a comprehensive, integrated, and structured approach to disaster recovery. Its overarching goal is to minimize the impact of the disaster on communities and help countries to recover quickly and e...
The overall goal of the programme, to reduce the malaria morbidity and mortality by 75% (using 2012 as baseline) by the year 2020, continued to be pursued in 2014. The following areas were identified as some of the priorities for the year: Malaria Case Management under which we have Malaria in Pregn...
Has the world worked together to tackle the coronavirus? July 2021. This research paper assesses how the global community has responded to calls for greater solidarity in tackling the COVID-19 pandemic, and presents the insights of key stakeholders and experts in global health governance, health sec...
The Global Antibiotic Resistance Partnership (GARP)-Mozambique team, in partnership with the Center for Disease Dynamics, Economics & Policy (CDDEP), has produced this report as part of a solid com-mitment to develop actionable policy proposals to tackle antibiotic resistance and improve appropriate...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
A practical guide for hospital administrators, health disaster coordinators, health facility designers, engineers and maintenance staff to achieve Smart Health Facilities by conserving resources, cutting costs, increasing efficiency in operations and reducing carbon emissions
This inter-agency guidance document aims to supplement the COVAX demand creation package for COVID-19 vaccines with key considerations for humanitarian contexts and marginalized populations with specific access and communication needs.
21 Sept.2021
This document is a guide for national authorities who are responsible for managing public health responses to COVID-19
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The publication provides an overview and analysis of international instruments that set standards related to the use of antimicrobials across the human, animal and plant sectors, and their release into the environment. The purpose of the document is to identify existing instruments and standards in ...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing global health and development landscape, considering the implications of integrating...
